Osteoarthritis Global Market Report 2024

Description

“Osteoarthritis Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on osteoarthritis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for osteoarthritis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The osteoarthritis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Treatment: Medication; Surgery; Therapy
2) By Diagnosis: Imaging; Joint Fluid Analysis
3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route
4) By Disease Type: Knee Osteoarthritis; Spine Osteoarthritis; Foot And Ankle Osteoarthritis; Shoulder Osteoarthritis; Hand Osteoarthritis
5) By End-User: Hospitals; Medical Institutes
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck Sharp & Dohme Corp.; Abbvie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Osteoarthritis is a type of arthritis that specifically impacts the joints, commonly affecting areas like the hands, knees, hips, neck, and lower back. This condition develops as the protective cartilage covering the ends of bones gradually wears away. The goal of osteoarthritis treatment is to alleviate pain, enhance joint function, and slow down the progression of the disease.

The primary treatments for osteoarthritis involve medication, surgical interventions, and therapy. Medication involves the use of drugs or pharmaceuticals to treat or alleviate the condition. Osteoarthritis pain can be managed with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and opioids. Diagnosis typically includes imaging studies and joint fluid analysis. Medications can be administered via different routes, including parenteral, topical, and oral, and are employed for treating various types of osteoarthritis, such as knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, and hand osteoarthritis. These treatments are primarily administered by healthcare professionals in hospitals and medical institutes.

The osteoarthritis market research report is one of a series of new reports from The Business Research Company that provides osteoarthritis market statistics, including osteoarthritis industry global market size, regional shares, competitors with an osteoarthritis market share, detailed osteoarthritis market segments, market trends and opportunities and any further data you may need to thrive in the osteoarthritis industry. This osteoarthritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The osteoarthritis market size has grown rapidly in recent years. It will grow from $6.24 billion in 2023 to $6.87 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to aging population, obesity epidemic, advances in imaging, pain management.

The osteoarthritis market size is expected to see strong growth in the next few years. It will grow to $9.69 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to non-pharmacological approaches, disease-modifying osteoarthritis drugs (dmoads), personalized medicine, telehealth and remote monitoring. Major trends in the forecast period include regenerative therapies, wearable devices, artificial intelligence in diagnosis, digital health tools.

The growth of the osteoarthritis market is anticipated to be significantly influenced by the rising prevalence of obesity-related disorders. Obesity-related disorders encompass a spectrum of health issues that can emerge due to excess body fat. This condition typically results from an imbalance between caloric intake and expenditure, often associated with the consumption of highly processed foods and excessive alcohol consumption. Obesity can contribute to the development of osteoarthritis by exerting increased stress on joints, inciting inflammation, and causing hormonal changes that elevate the burden on the joints. For example, according to the World Obesity Atlas 2022, published by the World Obesity Federation, it is projected that by 2030, 1 billion individuals worldwide, comprising 1 in 7 men and 1 in 5 women, will grapple with obesity. Furthermore, the report suggests that this trend will continue to escalate, with an estimated 4 billion people, equivalent to 51% of the global population, being classified as either overweight or obese by 2035. Thus, the surge in obesity-related disorders is a key driver behind the expansion of the osteoarthritis market.

The increasing utilization of pain relievers is poised to be a significant catalyst for the growth of the osteoarthritis market. Pain relievers encompass medications or substances designed to alleviate pain by diminishing the perception of discomfort. They play a pivotal role in mitigating pain associated with various conditions or injuries. The widespread application of pain relievers in the management of osteoarthritis, driven by the imperative need for effective pain management, holds considerable potential to impact the osteoarthritis market. This trend can lead to heightened demand, exert an influence on treatment protocols, stimulate research and development initiatives, and elevate awareness surrounding the condition. As an illustrative instance, in June 2022, the Consumer Healthcare Products Association reported that about 80% of respondents expressed that their utilization of over-the-counter pain relievers has either remained consistent (49%) or increased (30%) over the past two years. Consequently, the prevalent use of pain relievers is propelling the growth of the osteoarthritis market.

The osteoarthritis market's expansion during the forecast period faces a significant impediment in the form of high treatment costs. The elevated cost associated with osteoarthritis treatment can pose formidable barriers to access and treatment adherence, particularly affecting individuals with limited insurance coverage or those who lack insurance altogether. This circumstance often leads to delayed diagnosis and treatment, thereby exacerbating the progression of the disease and heightening the risk of complications. As an example, in 2021, the National Library of Medicine, a reputable biomedical library, reported an estimated annual cost range for osteoarthritis management per individual, spanning from $700 to $15,600. Consequently, the elevated cost of treatments represents a hindrance to the growth of the osteoarthritis market.

Major companies engaged in the osteoarthritis market are directing their efforts toward the development of novel products and advanced treatment modalities, including small molecule inhibitors, intra-articular hyaluronic acid injections, and single-injection viscosupplements, to fortify their foothold in the market. For instance, in August 2021, Seikagaku Corporation, a pharmaceutical and medical device company headquartered in Japan, introduced HyLink, a single-injection viscosupplement intended for intra-articular administration to address knee osteoarthritis. The core component of this product is a crosslinked hyaluronate hydrogel created using Seikagaku's proprietary crosslinking technique. HyLink is anticipated to offer enduring relief from symptoms with a minimal 3ml dosage, as the highly viscoelastic hyaluronate hydrogel remains within the knee joint cavity for an extended period, enhancing lubrication and reducing pain.

In July 2022, Bioventus Inc., a medical device company based in the United States, completed the acquisition of CartiHeal Ltd. for a sum of $450 million. This strategic acquisition is expected to enhance Bioventus' joint preservation technology. It bolsters Bioventus' standing as a leader in the joint preservation technology sector, aligning with Bioventus' objectives related to sports medicine and comprehensive joint reconstruction. CartiHeal Ltd., headquartered in Israel, specializes in the development of medical devices designed for the treatment of cartilage and osteochondral defects in both arthritic and non-arthritic knee joints. This acquisition is set to augment Bioventus' capabilities and offerings in this domain.

Major players in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

North America was the largest region in the osteoarthritis market in 2023. The regions covered in osteoarthritis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the osteoarthritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The osteoarthritis market consists of revenues earned by entities by providing services such as physical therapy, occupational therapy, weight management, exercise and physical activity, patient education, self-management programs and joint protection techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteoarthritis market also includes sales of viscosupplementation agents, analgesics, corticosteroids and assistive devices such as braces, canes, or shoe inserts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12368

1. Executive Summary

2. Osteoarthritis Market Characteristics

3. Osteoarthritis Market Trends And Strategies

4. Osteoarthritis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Osteoarthritis Market Size and Growth

5.1. Global Osteoarthritis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Osteoarthritis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Osteoarthritis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Osteoarthritis Market Segmentation

6.1. Global Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medication
Surgery
Therapy
6.2. Global Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Imaging
Joint Fluid Analysis
6.3. Global Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Parenteral Route
Topical Route
Oral Route
6.4. Global Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Knee Osteoarthritis
Spine Osteoarthritis
Foot And Ankle Osteoarthritis
Shoulder Osteoarthritis
Hand Osteoarthritis
6.5. Global Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Medical Institutes

7. Osteoarthritis Market Regional And Country Analysis

7.1. Global Osteoarthritis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Osteoarthritis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Osteoarthritis Market

8.1. Asia-Pacific Osteoarthritis Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Osteoarthritis Market

9.1. China Osteoarthritis Market Overview
9.2. China Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Osteoarthritis Market

10.1. India Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Osteoarthritis Market

11.1. Japan Osteoarthritis Market Overview
11.2. Japan Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Osteoarthritis Market

12.1. Australia Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Osteoarthritis Market

13.1. Indonesia Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Osteoarthritis Market

14.1. South Korea Osteoarthritis Market Overview
14.2. South Korea Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Osteoarthritis Market

15.1. Western Europe Osteoarthritis Market Overview
15.2. Western Europe Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Osteoarthritis Market

16.1. UK Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Osteoarthritis Market

17.1. Germany Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Osteoarthritis Market

18.1. France Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Osteoarthritis Market

19.1. Italy Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Osteoarthritis Market

20.1. Spain Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Osteoarthritis Market

21.1. Eastern Europe Osteoarthritis Market Overview
21.2. Eastern Europe Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Osteoarthritis Market

22.1. Russia Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Osteoarthritis Market

23.1. North America Osteoarthritis Market Overview
23.2. North America Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Osteoarthritis Market

24.1. USA Osteoarthritis Market Overview
24.2. USA Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Osteoarthritis Market

25.1. Canada Osteoarthritis Market Overview
25.2. Canada Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Osteoarthritis Market

26.1. South America Osteoarthritis Market Overview
26.2. South America Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Osteoarthritis Market

27.1. Brazil Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Osteoarthritis Market

28.1. Middle East Osteoarthritis Market Overview
28.2. Middle East Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Osteoarthritis Market

29.1. Africa Osteoarthritis Market Overview
29.2. Africa Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Osteoarthritis Market Competitive Landscape And Company Profiles

30.1. Osteoarthritis Market Competitive Landscape
30.2. Osteoarthritis Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck Sharp & Dohme Corp.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbvie Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Osteoarthritis Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Sanofi SA
31.3. AstraZeneca plc
31.4. Abbott Laboratories Incorporation
31.5. Eli Lilly and Company
31.6. Boehringer Ingelheim
31.7. Novo Nordisk A/S
31.8. Reckitt Benckiser Group plc
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Regeneron Pharmaceuticals Inc.
31.11. Mylan N.V.
31.12. Astellas Pharma Inc.
31.13. Zimmer Biomet Holdings Inc.
31.14. Eisai Co. Ltd.
31.15. Horizon Therapeutics plc

32. Global Osteoarthritis Market Competitive Benchmarking

33. Global Osteoarthritis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Osteoarthritis Market

35. Osteoarthritis Market Future Outlook and Potential Analysis

35.1 Osteoarthritis Market In 2028 - Countries Offering Most New Opportunities
35.2 Osteoarthritis Market In 2028 - Segments Offering Most New Opportunities
35.3 Osteoarthritis Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer